Copyright Reports & Markets. All rights reserved.

Global Natural Killer Cell Therapy Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Natural Killer Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 NK Cell Therapies
    • 1.2.3 NK Cell Directed Antibodies
  • 1.3 Market by Application
    • 1.3.1 Global Natural Killer Cell Therapy Market Share by Application: 2020 VS 2026
    • 1.3.2 Cancer
    • 1.3.3 Gastrointestinal Diseases
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Natural Killer Cell Therapy Market Perspective (2015-2026)
  • 2.2 Global Natural Killer Cell Therapy Growth Trends by Regions
    • 2.2.1 Natural Killer Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Natural Killer Cell Therapy Historic Market Share by Regions (2015-2020)
    • 2.2.3 Natural Killer Cell Therapy Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Natural Killer Cell Therapy Players by Market Size
    • 3.1.1 Global Top Natural Killer Cell Therapy Players by Revenue (2015-2020)
    • 3.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Players (2015-2020)
  • 3.2 Global Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Natural Killer Cell Therapy Revenue
  • 3.4 Global Natural Killer Cell Therapy Market Concentration Ratio
    • 3.4.1 Global Natural Killer Cell Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cell Therapy Revenue in 2019
  • 3.5 Key Players Natural Killer Cell Therapy Area Served
  • 3.6 Key Players Natural Killer Cell Therapy Product Solution and Service
  • 3.7 Date of Enter into Natural Killer Cell Therapy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Natural Killer Cell Therapy Breakdown Data by Type (2015-2026)

  • 4.1 Global Natural Killer Cell Therapy Historic Market Size by Type (2015-2020)
  • 4.2 Global Natural Killer Cell Therapy Forecasted Market Size by Type (2021-2026)

5 Natural Killer Cell Therapy Breakdown Data by Application (2015-2026)

  • 5.1 Global Natural Killer Cell Therapy Historic Market Size by Application (2015-2020)
  • 5.2 Global Natural Killer Cell Therapy Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Natural Killer Cell Therapy Market Size (2015-2026)
  • 6.2 North America Natural Killer Cell Therapy Market Size by Type (2015-2020)
  • 6.3 North America Natural Killer Cell Therapy Market Size by Application (2015-2020)
  • 6.4 North America Natural Killer Cell Therapy Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Natural Killer Cell Therapy Market Size (2015-2026)
  • 7.2 Europe Natural Killer Cell Therapy Market Size by Type (2015-2020)
  • 7.3 Europe Natural Killer Cell Therapy Market Size by Application (2015-2020)
  • 7.4 Europe Natural Killer Cell Therapy Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Natural Killer Cell Therapy Market Size (2015-2026)
  • 8.2 China Natural Killer Cell Therapy Market Size by Type (2015-2020)
  • 8.3 China Natural Killer Cell Therapy Market Size by Application (2015-2020)
  • 8.4 China Natural Killer Cell Therapy Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

(2015-2020)

    (2015-2020)

      .4 Natural Killer Cell Therapy Market Size by Country (2015-2020)

      • 9.4.1 Mexico
      • 9.4.2 Brazil

      .4 Natural Killer Cell Therapy Market Size by Country (2015-2020)

      • 10.4.1 Turkey
      • 10.4.2 Saudi Arabia
      • 10.4.3 UAE
      • 10.4.4 Rest of Middle East & Africa

      9Key Players Profiles

      • 9.1 Nektar Therapeutics
        • 9.1.1 Nektar Therapeutics Company Details
        • 9.1.2 Nektar Therapeutics Business Overview
        • 9.1.3 Nektar Therapeutics Natural Killer Cell Therapy Introduction
        • 9.1.4 Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2015-2020))
        • 9.1.5 Nektar Therapeutics Recent Development
      • 9.2 Innate Pharma SA
        • 9.2.1 Innate Pharma SA Company Details
        • 9.2.2 Innate Pharma SA Business Overview
        • 9.2.3 Innate Pharma SA Natural Killer Cell Therapy Introduction
        • 9.2.4 Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2015-2020)
        • 9.2.5 Innate Pharma SA Recent Development
      • 9.3 Affimed
        • 9.3.1 Affimed Company Details
        • 9.3.2 Affimed Business Overview
        • 9.3.3 Affimed Natural Killer Cell Therapy Introduction
        • 9.3.4 Affimed Revenue in Natural Killer Cell Therapy Business (2015-2020)
        • 9.3.5 Affimed Recent Development
      • 9.4 Chipscreen Biosciences
        • 9.4.1 Chipscreen Biosciences Company Details
        • 9.4.2 Chipscreen Biosciences Business Overview
        • 9.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Introduction
        • 9.4.4 Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2015-2020)
        • 9.4.5 Chipscreen Biosciences Recent Development
      • 9.5 Glycostem Therapeutics
        • 9.5.1 Glycostem Therapeutics Company Details
        • 9.5.2 Glycostem Therapeutics Business Overview
        • 9.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Introduction
        • 9.5.4 Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2015-2020)
        • 9.5.5 Glycostem Therapeutics Recent Development
      • 9.6 Fate Therapeutics
        • 9.6.1 Fate Therapeutics Company Details
        • 9.6.2 Fate Therapeutics Business Overview
        • 9.6.3 Fate Therapeutics Natural Killer Cell Therapy Introduction
        • 9.6.4 Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2015-2020)
        • 9.6.5 Fate Therapeutics Recent Development
      • 9.7 Dragonfly Therapeutics
        • 9.7.1 Dragonfly Therapeutics Company Details
        • 9.7.2 Dragonfly Therapeutics Business Overview
        • 9.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Introduction
        • 9.7.4 Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2015-2020)
        • 9.7.5 Dragonfly Therapeutics Recent Development
      • 9.8 Kiadis Pharma
        • 9.8.1 Kiadis Pharma Company Details
        • 9.8.2 Kiadis Pharma Business Overview
        • 9.8.3 Kiadis Pharma Natural Killer Cell Therapy Introduction
        • 9.8.4 Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2015-2020)
        • 9.8.5 Kiadis Pharma Recent Development
      • 9.9 Nkarta Therapeutics
        • 9.9.1 Nkarta Therapeutics Company Details
        • 9.9.2 Nkarta Therapeutics Business Overview
        • 9.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Introduction
        • 9.9.4 Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2015-2020)
        • 9.9.5 Nkarta Therapeutics Recent Development
      • 9.10 NantKwest
        • 9.10.1 NantKwest Company Details
        • 9.10.2 NantKwest Business Overview
        • 9.10.3 NantKwest Natural Killer Cell Therapy Introduction
        • 9.10.4 NantKwest Revenue in Natural Killer Cell Therapy Business (2015-2020)
        • 9.10.5 NantKwest Recent Development

      10Analyst's Viewpoints/Conclusions

        11Appendix

        • 11.1 Research Methodology
          • 11.1.1 Methodology/Research Approach
          • 11.1.2 Data Source
        • 11.2 Disclaimer

        Natural Killer Cell Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Natural Killer Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

        Market segment by Type, the product can be split into
        NK Cell Therapies
        NK Cell Directed Antibodies

        Market segment by Application, split into
        Cancer
        Gastrointestinal Diseases
        Others

        Based on regional and country-level analysis, the Natural Killer Cell Therapy market has been segmented as follows:
        North America
        United States
        Canada
        Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic
        Rest of Europe
        Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia-Pacific
        Latin America
        Mexico
        Brazil
        Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of Middle East & Africa

        In the competitive analysis section of the report, leading as well as prominent players of the global Natural Killer Cell Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
        The key players covered in this study
        Nektar Therapeutics
        Innate Pharma SA
        Affimed
        Chipscreen Biosciences
        Glycostem Therapeutics
        Fate Therapeutics
        Dragonfly Therapeutics
        Kiadis Pharma
        Nkarta Therapeutics
        Buy now